← Eichor
Study identifier: NCT05142800 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Screening For BCRL In Targeted Therapy For Breast Cancer

Condition: Lymphedema · Lymphedema Arm · Lymphedema of Upper Arm  ·  Sponsor: Massachusetts General Hospital

PhaseN/A
Planned participants261
Who can joinFemale, 18 Years to 80 Years
Healthy volunteersNo

About this study

This a prospective, longitudinal study designed to track edema and Breast Cancer Related Lymphedema (BCRL) onset in breast cancer patients taking targeted therapy treatments for early and metastatic breast cancer. A Perometer and Sozo devise will be used to measure volume changes

This description comes directly from the study's public registry record.

Talk to the study team

Alphonse G. Taghian, MD  ·  617-643-1306  ·  ataghian@partners.org

Always discuss trial participation with your own doctor first.

Locations (1)

Massachusetts General HospitalBoston, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05142800